As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and AR ON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution. What’s the opportunity? Parabilis is seeking an accomplished Associate Director of Medicinal Chemistry – Synthesis with deep expertise in small-molecule synthesis to lead a team advancing compounds from hit identification through lead optimization and candidate nomination. This leader will apply innovative synthetic strategies, data-driven execution, and strong cross-functional collaboration to accelerate high-impact discovery programs. The successful candidate will provide scientific and strategic leadership, mentor and develop synthesis chemists, and play a critical role in advancing the company’s portfolio. You will join a medicinal chemistry synthesis team that is central to Parabilis’s discovery engine and pipeline, focused on therapeutically important and historically “undruggable” targets. This individual will lead synthesis efforts across Helicon degrader programs and collaborate closely with Chemistry Design, Biology, Data Science, and Computational Science teams. The role includes full ownership of synthesis strategy and execution, with opportunities to lead cross-functional program teams in delivering development candidates.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree